Skip to main content
Clinical Trials/NCT01108289
NCT01108289CompletedNot Applicable

The Oxytocin Initiative: Determining the Effect of Prophylactic Administration of Oxytocin in Uniject™ by a Community Health Officer on Postpartum Hemorrhage at Home Births in Four Districts in Ghana

Johns Hopkins Bloomberg School of Public Health1 site in 1 country1,586 target enrollmentStarted: April 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,586
Locations
1
Primary Endpoint
postpartum hemorrhage-1

Study Overview

Brief Summary

This study is designed to test the hypothesis that the intramuscular administration of 10 IU of oxytocin in Uniject™ during the third stage of labor by a Community Health Officer (CHO) at home births in Ghana will reduce the risk of postpartum hemorrhage by 50 percent relative to home births attended by the same type of provider who does not provide a uterotonic drug.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
15 Years to 50 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •home delivery
  • •presence of Community Health Officer at time of delivery

Exclusion Criteria

  • Not provided

Arms & Interventions

Oxytocin in Uniject

Experimental

Community Health Officers will provide 10 IU Oxytocin in Uniject device IM immediately after delivery of baby

Intervention: Oxytocin in Uniject (Other)

PPH Treatment Only

No Intervention

Community Health Officers will be able to treat for PPH only, not provide Oxytocin in Uniject

Outcomes

Primary Outcomes

postpartum hemorrhage-1

Time Frame: after delivery of baby

blood loss \>=500 ml after delivery of the baby, as measured through plastic calibrated drape

postpartum hemorrhage-2

Time Frame: after delivery of the baby

blood loss \>=500ml OR treatment dose of oxytocin provided

postpartum hemorrhage-3

Time Frame: after delivery of the baby

blood loss \>=500ml OR treatment dose of oxytocin provided OR referral for bleeding

Secondary Outcomes

  • Oxytocin use before delivery(labor and delivery)
  • stillbirth(labor/delivery)
  • neonatal death(first month of life)
  • need for neonatal resuscitation(0-6 hours after birth)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials